Advertisement

Enforcement & Compliance

FDA to target high-risk alternative remedies

FDA to target high-risk alternative remedies

The Food and Drug Administration issued a new proposal for regulating homeopathic medicines that have long been on the fringe of mainstream medicine. The agency plans to target products that pose the biggest safety risks, including those marketed for children or for serious diseases.

DaVita's pharmacy unit reaches $63.7 million false claims settlement

DaVita's pharmacy unit reaches $63.7 million false claims settlement

DaVita Rx, the pharmacy services unit of kidney dialysis giant DaVita, will pay $63.7 million to settle allegations that it presented false claims to the federal government for prescription medications, and that it provided unlawful financial incentives to Medicare beneficiaries.

Intermountain Healthcare to pay $1M settlement in drug case

Intermountain Healthcare to pay $1M settlement in drug case

The Salt Lake City-based health system will pay the federal government $1 million to settle allegations that a former medical assistant illegally diverted thousands of painkillers and other pills for personal use by herself and family members.

FDA to pave clearer path for generic drugs

FDA to pave clearer path for generic drugs

The FDA's new guidance aims to make it easier for generic firms to plan how they can copy complex drugs like epinephrine auto-injectors, which should ultimately lower pharmaceutical prices.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print